Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Mood Disorders | Research article

Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study

Authors: Amjad Khan, Amer Hayat Khan, Azreen Syazril Adnan, Syed Azhar Syed Sulaiman, Saima Mushtaq

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Even though depression is one of the most common psychiatric disorders, it is under-recognized in hemodialysis (HD) patients. Existing literature does not provide enough information on evaluation of predictors of depression among HD patients. The objective of the current study was to determine the prevalence and predictors of depression among HD patients.

Methods

A multicenter prospective follow-up study. All eligible confirmed hypertensive HD patients who were consecutively enrolled for treatment at the study sites were included in the current study. HADS questionnaire was used to assess the depression level among study participants. Patients with physical and/or cognitive limitations that prevent them from being able to answer questions were excluded.

Results

Two hundred twenty patients were judged eligible and completed questionnaire at the baseline visit. Subsequently, 216 and 213 patients completed questionnaire on second and final follow up respectively. The prevalence of depression among patients at baseline, 2nd visit and final visit was 71.3, 78.2 and 84.9% respectively. The results of regression analysis showed that treatment given to patients at non-governmental organizations (NGO’s) running HD centers (OR = 0.347, p-value = 0.039) had statistically significant association with prevalence of depression at final visit.

Conclusions

Depression was prevalent in the current study participants. Negative association observed between depression and hemodialysis therapy at NGO’s running centers signifies patients’ satisfaction and better depression management practices at these centers.
Literature
1.
2.
Turkistani I, et al. The prevalence of anxiety and depression among end-stage renal disease patients on hemodialysis in Saudi Arabia. Ren Fail. 2014;36(10):1510–5.PubMedCrossRef
3.
Wa Wang L-J, Chen C-K. The Psychological impact of hemodialysis on patients with chronic renal failure. In: Renal failure-the facts; 2012. InTech.
4.
Van Biesen W, et al. Fluid status in peritoneal dialysis patients: the European body composition monitoring (EuroBCM) study cohort. PLoS One. 2011;6(2):e17148.PubMedPubMedCentralCrossRef
5.
Chertow GM, et al. Bioimpedance norms for the hemodialysis population. Kidney Int. 1997;52(6):1617–21.PubMedCrossRef
6.
Kimmel PL, et al. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003;42(4):713–21 91 & 126 & 285.PubMedCrossRef
7.
Stasiak CES, et al. Prevalence of anxiety and depression and its comorbidities in patients with chronic kidney disease on hemodialysis and peritoneal dialysis. J Bras Nefrol. 2014;36(3):325–31.PubMedCrossRef
8.
Wu AW, et al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol. 2004;15(3):743–53.PubMedCrossRef
9.
Ginieri-Coccossis M, et al. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: investigating differences in early and later years of current treatment. BMC Nephrol. 2008;9(1):14.PubMedPubMedCentralCrossRef
10.
Varela L, et al. Predictores psicológicos de la calidad de vida relacionada con la salud en pacientes en tratamiento de diálisis peritoneal. Nefrología (Madrid). 2011;31(1):97–106.
11.
Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRef
12.
Whelan-Goodinson R, Ponsford J, Schönberger M. Validity of the hospital anxiety and depression scale to assess depression and anxiety following traumatic brain injury as compared with the structured clinical interview for DSM-IV. J Affect Disord. 2009;114(1):94–102.PubMedCrossRef
13.
Yahya F, Othman Z. Validation of the Malay version of hospital anxiety and depression scale (HADS) in Hospital Universiti Sains Malaysia. Int Med J. 2015;22:80–2.
14.
Bjelland I, et al. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.PubMedCrossRef
15.
Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923–36.PubMedCrossRef
16.
Bossola M, et al. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. Gen Hosp Psychiatry. 2010;32(2):125–31 168 & 192.PubMedCrossRef
17.
Taskapan H, et al. Psychiatric disorders and large interdialytic weight gain in patients on chronic haemodialysis. Nephrology. 2005;10(1):15–20.PubMedCrossRef
18.
Drayer RA, et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry. 2006;28(4):306–12.PubMedCrossRef
19.
Kalender B, et al. Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract. 2007;61(4):569–76.PubMedCrossRef
20.
Cukor D, et al. Course of depression and anxiety diagnosis in patients treated with hemodialysis: a 16-month follow-up. Clin J Am Soc Nephrol. 2008;3(6):1752–8.PubMedPubMedCentralCrossRef
21.
Hedayati SS, et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008;74(7):930–6.PubMedCrossRef
22.
Ibrahim S, El Salamony O. Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol. 2008;28(5):784–91.PubMedCrossRef
23.
Hsu HJ, Chen C-K, Wu M-S. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers. Am J Nephrol. 2009;29(6):592–7.PubMedCrossRef
24.
Kao TW, et al. Economic, social, and psychological factors associated with health-related quality of life of chronic hemodialysis patients in northern Taiwan: a multicenter study. Artif Organs. 2009;33(1):61–8 254 & 286.PubMedCrossRef
25.
Montinaro V, et al. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Clin Nephrol. 2010;73(1):36.PubMedCrossRef
26.
Preljevic VT, et al. Screening for anxiety and depression in dialysis patients: comparison of the hospital anxiety and depression scale and the Beck depression inventory. J Psychosom Res. 2012;73(2):139–44 (171 & 195).PubMedCrossRef
27.
Tavallaii SA, et al. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur J Intern Med. 2009;20(4):411–4 174 & 198.CrossRef
28.
Keskin G, Engin E. The evaluation of depression, suicidal ideation and coping strategies in haemodialysis patients with renal failure. J Clin Nurs. 2011;20(19–20):2721–32.PubMedCrossRef
29.
Araujo SM, et al. Risk factors for depressive symptoms in a large population on chronic hemodialysis. Int Urol Nephrol. 2012;44(4):1229–35.PubMedCrossRef
30.
Farrokhi F, et al. Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(4):623–35.PubMedCrossRef
31.
Boulware LE, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol. 2006;1(3):496–504.PubMedCrossRef
32.
Kimmel PL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000;57(5):2093–8.PubMedCrossRef
33.
Van den Beukel TO, Verdujin M, Boeschoten EW, Krediet RT, Dekker FW, Van Dijk S. The association of baseline, newonset, and persistent depressive symptoms with mortality in ESRD patients. In: Proceedings of the American Society of Nephrology Renal Week; November 16-21, 2010; Denver, CO. Abstract TH-PO529.
34.
Hedayati SS, et al. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. Jama. 2010;303(19):1946–53.PubMedCrossRef
35.
Tsai Y-C, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.PubMedCrossRef
36.
37.
Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res. 2002;53(4):873–6.PubMedCrossRef
38.
Bilgic A, et al. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr. 2007;17(6):381–8.PubMedCrossRef
39.
Cukor D, et al. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223–9.PubMedCrossRef
40.
Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72(3):227–36.PubMedCrossRef
41.
Schoevers R, et al. Depression and excess mortality: evidence for a dose response relation in community living elderly. Int. J. Geriatr. Psychiatry. 2009;24(2):169–76.PubMedCrossRef
42.
Lopes AA, et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 2004;66(5):2047–53.PubMedCrossRef
43.
Hedayati S, et al. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006;69(9):1662–8.PubMedCrossRef
44.
Blumenfield M, et al. Fluoxetine in depressed patients on dialysis. Int. J. Psychiatry Med. 1997;27(1):71–80.PubMedCrossRef
45.
Spigset O, et al. Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis. Eur J Clin Pharmacol. 2000;56(9–10):699–703.PubMedCrossRef
46.
Wuerth, D., S.H. Finkelstein, and F.O. Finkelstein. Psychosocial factors in patients with chronic kidney disease: the identification and treatment of depression in patients maintained on dialysis. In Seminars in dialysis. 2005. Wiley Online Library.
47.
Duarte PS, et al. Cognitive–behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int. 2009;76(4):414–21.PubMedCrossRef
48.
Ouzouni S, et al. Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin Rehabil. 2009;23(1):53–63.PubMedCrossRef
49.
Rabindranath KS, et al. Physical measures for treating depression in dialysis patients. Cochrane Database Syst Rev. 2005;1(2):4-9.
50.
Nagler EV, et al. Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European renal best practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736–45.PubMedCrossRef
51.
Nolen-Hoeksema S. Gender differences in depression. Curr Dir Psychol Sci. 2001;10(5):173–6.CrossRef
52.
Theofilou P. Depression and anxiety in patients with chronic renal failure: the effect of sociodemographic characteristics. Int J Nephrol. 2011;2011:169–93.CrossRef
53.
Lopes GB, et al. Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clinical Practice. 2010;115(1):c35–40.PubMedCrossRef
54.
House AA, et al. Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010;25(5):1416–20.PubMedCrossRef
55.
Dohrenwend BP, et al. Socioeconomic status and psychiatric disorders: the causation-selection issue. Science. 1992;255(5047):946–52.PubMedCrossRef
56.
Miech RA, Shanahan MJ. Socioeconomic status and depression over the life course. J Health Soc Behav. 2000;41(2):162–76.CrossRef
57.
Link BG, Lennon MC, Dohrenwend BP. Socioeconomic status and depression: the role of occupations involving direction, control, and planning. Am J Sociol. 1993;98(6):1351–87.CrossRef
58.
Chiang C-K, et al. Health-related quality of life of hemodialysis patients in Taiwan: a multicenter study. Blood Purif. 2004;22(6):490–8.PubMedCrossRef
59.
Østhus TBH, et al. Health-related quality of life and depression in dialysis patients: associations with current smoking. Scand J Urol Nephrol. 2010;44(1):46–55.PubMedCrossRef
60.
Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care. 2003;26(1):104–11.PubMedCrossRef
61.
Breslau N, et al. Major depression and stages of smoking: a longitudinal investigation. Arch Gen Psychiatry. 1998;55(2):161–6.PubMedCrossRef
62.
Pasco JA, et al. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008;193(4):322–6.PubMedCrossRef
63.
Sarna L, et al. Impact of smoking and smoking cessation on health-related quality of life in women in the nurses’ health study. Qual Life Res. 2008;17(10):1217–27.PubMedPubMedCentralCrossRef
64.
Anda RF, et al. Depression and the dynamics of smoking: a national perspective. Jama. 1990;264(12):1541–5.PubMedCrossRef
65.
66.
Thorndike AN, et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med. 2008;168(2):186–91.PubMedCrossRef
67.
Straube BM. Do health outcomes vary by profit status of hemodialysis units? Clin J Am Soc Nephrol. 2014;9(1):1–2.PubMedCrossRef
68.
69.
70.
71.
Sekkarie MA, et al. The Syrian conflict: assessment of the ESRD system and response to hemodialysis needs during a humanitarian and medical crisis. Kidney Int. 2015;87(2):262–5.PubMedCrossRef
72.
Georgi A, et al. Resource settings have a major influence on the outcome of maintenance hemodialysis patients in South India. Hemodial Int. 2010;14(2):211–7.CrossRef
73.
Lim T-O, et al. How public and private reforms dramatically improved access to dialysis therapy in Malaysia. Health Aff. 2010;29(12):2214–22.CrossRef
74.
Anees M, et al. Depression in hemodialysis patients. Pak J Med Sci. 2008;24(4):560–5.
Metadata
Title
Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study
Authors
Amjad Khan
Amer Hayat Khan
Azreen Syazril Adnan
Syed Azhar Syed Sulaiman
Saima Mushtaq
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-6796-z

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue

Research article

Burnout among school teachers: quantitative and qualitative results from a follow-up study in southern Sweden

Study protocol

Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial

Debate

Public health effects of gambling – debate on a conceptual model

Research article

Health shocks, care-seeking behaviour and coping strategies of extreme poor households in Bangladesh’s Chittagong Hill tracts

Research article

Evaluation of an intervention to promote walking during the commute to work: a cluster randomised controlled trial

Research article

Effect and cost of two successive home visits to increase HIV testing coverage: a prospective study in Lesotho, Southern Africa